ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Archives for September 2016

Glen Weiss, MD, MBA

on: September 01, 2016In: Names & News
Glen Weiss, MD, MBA

Glen Weiss, MD, MBA, was named 2016 Healthcare Leadership Awards’ Researcher of the Year by AZ Business magazine. Dr. Weiss is Director of Clinical Research, Director of Phase I and II […] Read more


David Spigel, MD

on: September 01, 2016In: Names & News
David Spigel, MD

David Spigel has been appointed chief scientific officer of Sarah Cannon Research Institute, Nashville, US, and will oversee the development and operations of Sarah Cannon’s clinical research program. Dr. Spigel joined […] Read more

Mark A. Socinski, MD

on: September 01, 2016In: Names & News
Mark A. Socinski, MD

Mark A. Socinski has been appointed Executive Medical Director of the Florida Hospital Cancer Institute, and will oversee the coordination of clinical cancer services for the Florida Hospital network. He will […] Read more

David H. Johnson, MD

on: September 01, 2016In: Names & News
David H. Johnson, MD

David H. Johnson received the 2016 ASCO Distinguished Achievement Award, which is given annually and recognizes leadership or mentorship by a scientist, practitioner, or researcher who has benefited patients with cancer […] Read more

Jeffrey Engelman, MD, PhD

on: September 01, 2016In: Names & News
Jeffrey Engelman, MD, PhD

Jeffrey Engelman has been appointed Vice President and Global Head of Oncology at the Novartis Institutes of BioMedical Research. Prior to joining Novartis, Dr. Engelman was Director of the Center for […] Read more

Laurie Fenton Ambrose

on: September 01, 2016In: Names & News
Laurie Fenton Ambrose

Laurie Fenton Ambrose received the 2016 James L. Mulshine, MD Leadership Award, which recognized her efforts in guiding patient advocacy and other stakeholder groups in the successful efforts to gain […] Read more

Jean-Marie Cuillerot, MD

on: September 01, 2016In: Names & News
Jean-Marie Cuillerot, MD

Jean-Marie Cuillerot has been appointed Vice President and Global Head of Clinical Development at Agenus, Inc, Lexington, US, overseeing ongoing clinical development of checkpoint targeted antibodies, including AGEN1884 targeting CTLA-4 and […] Read more

Anton Berns, PhD, FAACR

on: September 01, 2016In: Names & News
Anton Berns, PhD, FAACR

Anton Berns was elected to the National Academy of Sciences (NAS). NAS membership is in recognition of distinguished and continuing achievements in original research. Dr. Berns is the Senior Group Leader […] Read more

Today’s Age of Drug Development Q & A with Kapil Dhingra, MD

on: September 01, 2016In: Global Initiatives
Today’s Age of Drug Development Q & A with Kapil Dhingra, MD

By Cynthia L. Kryder, MS IASLC Lung Cancer News recently spoke with Kapil Dhingra, MD, of KAPital Consulting LLC in Sparta, New Jersey, about oncologic drug development and the challenges […] Read more

Next-Generation Sequencing Across the World: Reports from France, Germany, and China

on: September 01, 2016In: Global Initiatives
Next-Generation Sequencing Across the World: Reports from France, Germany, and China

Next-generation sequencing (NGS) technology has revolutionized genomic and genetic research as it fulfills its potential to tailor the treatment of cancer patients in general and non-small cell lung cancer (NSCLC) […] Read more

123

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy